Cotizaciones actuales de Conduit Pharmaceuticals Inc. - Common Stock

Bolsa	Ticker	Moneda	Última operación	Precio	Variación diaria
NASDAQ	CDT	USD	13.06.2025 23:49	2,40 USD	2,43 USD -1,37 %

Performance

Jour	Semaine	Mois	3 mois	6 mois	1 an	5 ans
0,00 %	-8,10 %	-59,19 %	-84,39 %	-98,00 %	-99,92 %	-99,98 %

Profil de l'entreprise pour Conduit Pharmaceuticals Inc. - Common Stock Action

Conduit Pharmaceuticals Inc. operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. It's pipeline includes AZD1656 for the treatment of hashimoto's thyroiditis, renal transplant, uveitis, and preterm labor; and AZD5904 for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.

Données de l'entreprise

Nom Conduit Pharmaceuticals Inc. - Common Stock

Société Conduit Pharmaceuticals Inc.

Symbole CDT

Site web https://www.conduitpharma.com

Marché d'origine

NASDAQ

ISIN US20678X1063

Type de titre Action

Secteur Healthcare

Industrie Biotechnology

PDG Dr. David Joszef Tapolczay

Pays États-Unis d'Amérique

Devise USD

Employés 0,0 T

Adresse 4995 Murphy Canyon Road, 92134 San Diego

Date d'introduction en bourse 2022-03-28

Stock Splits

Date	Split
20.05.2025	1:15
27.01.2025	1:100

ID Changes

Date	From	To
25.09.2023	MURF	CDT

Ticker Symbols

Name	Symbol
Frankfurt	ZK7.F
NASDAQ	CDT

More Shares

Investors who Conduit Pharmaceuticals Inc. - Common Stock hold also have the following shares in their portfolio:

DWS MULTI OPPORTUNITIES LD Fund

WAADT KT 12-22 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog